No Result
View All Result
SUBSCRIBE | NO FEES, NO PAYWALLS
MANAGE MY SUBSCRIPTION
NEWSLETTER
Corporate Compliance Insights
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Career Connection
  • Events
    • Calendar
    • Submit an Event
  • Library
    • Whitepapers & Reports
    • eBooks
    • CCI Press & Compliance Bookshelf
  • Podcasts
  • Videos
  • Subscribe
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Career Connection
  • Events
    • Calendar
    • Submit an Event
  • Library
    • Whitepapers & Reports
    • eBooks
    • CCI Press & Compliance Bookshelf
  • Podcasts
  • Videos
  • Subscribe
No Result
View All Result
Corporate Compliance Insights
Home Compliance

What the Olympus Corporate Integrity Agreement Can Teach Us

by Thomas Fox
March 16, 2016
in Compliance
Olympus' history of bribery and corruption has left the corporation with a strict CIA

This article was republished with permission from Tom Fox’s FCPA Compliance and Ethics Blog.

The recent Olympus Corporation and related entities (collectively “Olympus”) enforcement action demonstrated a company seemingly dedicated to lying, cheating and stealing its way across the globe in search of the almighty dollar. As noted by Mike Volkov, “Olympus bears the unique moniker of completing a triple play of misconduct – violations of the domestic anti-kickback statute, the False Claims Act and the Foreign Corrupt Practices Act (FCPA). At the root of its problem is a culture committed to bribery and kickbacks.”

Added to this ignominy was that the company’s Chief Compliance Officer (CCO), John Slowik, tried to stop these actions internally and was fired for his trouble. Thereafter he filed a whistleblower claim and a Qui Tam case. According to the Department of Justice (DOJ) press release on the resolution, he was awarded over $51 million for his bringing the illegal acts to light.

The company, the U.S.’ largest distributor of endoscopes and related equipment, had engaged in a scheme to pay kickbacks to doctors and hospitals in the U.S. No doubt not wanting to be out of balance with its international sales, the company violated the FCPA in Latin America. Much has been and will continue to be written about the nefarious acts of the company; its long and widespread bribery schemes all tied together with an endemic culture of corruption as lessons to be learned by the anti-corruption compliance practitioner.

However, as this matter encompassed more than simply the FCPA and it was in the health care space, in addition to entering into a deferred prosecution agreement (DPA), the company entered into a corporate integrity agreement (CIA). This CIA has some very detailed instruction on the compliance program the company must put in place going forward. I realize that much of the detail relates to the specific health care requirements of the Office of Inspector General (OIG) and the Department of Health and Human Services (HHS); nevertheless, the CIA provides some interesting guideposts for you to consider in your own FCPA compliance program. Over the next couple of blog posts I will detail out some of the more interesting requirements under the CIA. Today, I will start with an overview.

According the to the DOJ press release, “The CIA details the compliance program [Olympus Corporation of the Americas (OCA)] must maintain, which must include:

  • compliance responsibilities for OCA management and the Board of Directors;
  • a health care compliance code of conduct that includes certain standards;
  • training and education that includes specified standards;
  • requirements for consulting arrangements, grants and charitable contributions, management of field assets and review of travel expenses;
  • risk assessment and mitigation process; and
  • review procedures for testing the compliance program.”

Under the CIA, Olympus “represents that it has implemented a compliance program that includes the following elements: a compliance officer, a compliance committee, training and education, policies and procedures, a hotline for reporting compliance issues and monitoring and auditing activities. [Olympus] shall continue its compliance program throughout the term of this CIA and shall do so in accordance with the terms set forth below. OCA may modify its compliance program as appropriate but, at a minimum, OCA shall ensure that during the term of this CIA, it shall comply with the obligations.” The CIA had two obligations that provide insights into how a compliance program should be structured.

Compliance Committee

Within 90 days following the execution of the CIA, the company is required to create a compliance committee. Interestingly, the CIA laid out who should be on this compliance committee. Of course, it included the CCO and other members of senior management necessary to meet the requirements of the CIA, but went on to suggest senior management from the following functions, “senior executives of relevant departments, such as sales, marketing, legal, medical affairs/medical information, regulatory affairs, research and development, human resources, audit, finance, manufacturing and operations.”

Even the functional leadership of the compliance committee was specified with the CCO as a co-chair with the Chief Executive Officer (CEO). Meeting dates were specified to occur at least quarterly with minutes kept and available to the OIG. Changes in committee membership also had to be approved by the OIG.

Board of Directors

The CIA recognized the Board has the responsibility for the “review and oversight of matters related to compliance with federal health care program requirements, FDA requirements and the obligations of this CIA.” The Board itself is required to include a non-executive member. The CIA went on to lay out specific requirements for the Board around its oversight of the compliance function.

It stated the Board is required to meet no less than quarterly to review and oversee the compliance program. The Board must report to the OIG, “description of the documents and other materials it reviewed, as well as any additional steps taken, such as the engagement of an independent advisor or other third-party resources, in its oversight of the compliance program and in support of making the resolution below during each reporting period.”

Most interestingly, under the CIA, the Board is required to adopt “a resolution, signed by each individual member of the Board, summarizing its review and oversight of OCA’s compliance with federal health care program requirements, FDA requirements and the obligations of this CIA” during each reporting period.

Finally, the CIA even required specific language in each Board resolution, reading “the Board of Directors has made a reasonable inquiry into the operations of OCA’s compliance program during the preceding 12-month period including the performance of the compliance officer and the compliance committee. Based on its inquiry and review, the Board has concluded that, to the best of its knowledge, OCA has implemented an effective compliance program to meet federal health care program requirements, FDA requirements and the obligations of the corporate integrity agreement.” If the Board cannot commit to this language, it must explain why not in writing to the OIG.

Admittedly, these provisions may seem onerous for a company who has not engaged in multiple criminal acts. However, these steps are required to ensure that Olympus fulfills its obligations going forward. Yet the requirements lay out what may move to best practices for an anti-corruption compliance program sooner rather than later. Consider the makeup of the compliance committee and its specified regular meeting schedule. Moreover, the Board obligations could be seen as cutting edge, but also drill down into how a Board can effectively provide oversight to a compliance program. Finally, the certification required on the Board resolutions will hopefully make each and every Board member take their oversight responsibilities seriously.

This publication contains general information only and is based on the experiences and research of the author. The author is not, by means of this publication, rendering business advice, legal advice or other professional advice or services. This publication is not a substitute for such legal advice or services, nor should it be used as a basis for any decision or action that may affect your business. Before making any decision or taking any action that may affect your business, you should consult a qualified legal advisor. The author, his affiliates and related entities shall not be responsible for any loss sustained by any person or entity that relies on this publication. The author gives his permission to link, post, distribute or reference this article for any lawful purpose, provided attribution is made to the author. The author can be reached at 16.


Previous Post

New Frontiers in Compliance

Next Post

Kroll 2016 Anti-Bribery and Corruption Benchmarking Report

Thomas Fox

Thomas Fox

Thomas Fox has practiced law in Houston for 25 years. He is now assisting companies with FCPA compliance, risk management and international transactions. He was most recently the General Counsel at Drilling Controls, Inc., a worldwide oilfield manufacturing and service company. He was previously Division Counsel with Halliburton Energy Services, Inc. where he supported Halliburton’s software division and its downhole division, which included the logging, directional drilling and drill bit business units. Tom attended undergraduate school at the University of Texas, graduate school at Michigan State University and law school at the University of Michigan. Tom writes and speaks nationally and internationally on a wide variety of topics, ranging from FCPA compliance, indemnities and other forms of risk management for a worldwide energy practice, tax issues faced by multi-national US companies, insurance coverage issues and protection of trade secrets. Thomas Fox can be contacted via email at tfox@tfoxlaw.com or through his website www.tfoxlaw.com. Follow this link to see all of his articles.

Related Posts

Phaxis 100 dollars

AML & KYC: Addressing Key Challenges for 2023 and Beyond

by Alex Roberto
March 16, 2023

(Sponsored) In today’s world, financial criminals are often a step ahead of regulators and financial institutions who struggle to effectively...

audit

IIA Survey: Technology Issues Widening Risk Landscape

by Staff and Wire Reports
March 15, 2023

The past year has seen internal audit staffing and budgets continue their recovery to pre-pandemic levels as organizations contend with...

Paul Weiss Economic Sanctions and AML Developments 2022_f

Economic Sanctions and AML Developments

by Corporate Compliance Insights
March 15, 2023

Sanctions start high and stay high 2022 Year in Review Economic Sanctions and AML Developments What’s in this report from...

insider fraud threat

As Layoffs Continue, the Potential for Insider Fraud Is Growing. Are You Ready?

by Chris Gerda
March 15, 2023

From startups to big banks, the technology and financial services sector have already seen tens of thousands of layoffs in...

Next Post
Kroll 2016 Anti-Bribery and Corruption Benchmarking Report

Kroll 2016 Anti-Bribery and Corruption Benchmarking Report

Compliance Job Interview Q&A

Jump to a Topic

AML Anti-Bribery Anti-Corruption Artificial Intelligence (AI) Automation Banking Board of Directors Board Risk Oversight Business Continuity Planning California Consumer Privacy Act (CCPA) Code of Conduct Communications Management Corporate Culture COVID-19 Cryptocurrency Culture of Ethics Cybercrime Cyber Risk Data Analytics Data Breach Data Governance DOJ Download Due Diligence Enterprise Risk Management (ERM) ESG FCPA Enforcement Actions Financial Crime Financial Crimes Enforcement Network (FinCEN) GDPR HIPAA Know Your Customer (KYC) Machine Learning Monitoring RegTech Reputation Risk Risk Assessment SEC Social Media Risk Supply Chain Technology Third Party Risk Management Tone at the Top Training Whistleblowing
No Result
View All Result

Privacy Policy

Founded in 2010, CCI is the web’s premier global independent news source for compliance, ethics, risk and information security. 

Got a news tip? Get in touch. Want a weekly round-up in your inbox? Sign up for free. No subscription fees, no paywalls. 

Follow Us

Browse Topics:

  • CCI Press
  • Compliance
  • Compliance Podcasts
  • Cybersecurity
  • Data Privacy
  • eBooks Published by CCI
  • Ethics
  • FCPA
  • Featured
  • Financial Services
  • Fraud
  • Governance
  • GRC Vendor News
  • HR Compliance
  • Internal Audit
  • Leadership and Career
  • On Demand Webinars
  • Opinion
  • Resource Library
  • Risk
  • Uncategorized
  • Videos
  • Webinars
  • Well-Being
  • Whitepapers

© 2022 Corporate Compliance Insights

No Result
View All Result
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Career Connection
  • Events
    • Calendar
    • Submit an Event
  • Library
    • Whitepapers & Reports
    • eBooks
    • CCI Press & Compliance Bookshelf
  • Podcasts
  • Videos
  • Subscribe

© 2022 Corporate Compliance Insights

Welcome to CCI. This site uses cookies. Please click OK to accept. Privacy Policy
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT